Clonal hematopoiesis and circulating biomarkers in cardiovascular diseases.
Blood cell mutations linked to hematologic cancer also drive inflammation and heart disease, revealing a cross-specialty disease mechanism.
This review examines the intersection of clonal hematopoiesis and circulating biomarkers in cardiovascular disease, synthesizing evidence that CHIP-associated somatic mutations drive inflammatory cardiovascular phenotypes measurable through blood-based markers. The topic bridges hematologic malignancy precursors and cardiometabolic disease, an increasingly recognized cross-specialty link.
What the study was
- Study design
- Review / mini-review
- Population
- Cardiovascular disease patients with clonal hematopoiesis
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Fukushima Journal of Medical Science
Why it surfaced
CHIP-cardiovascular nexus is an active research area; review adds little novelty but serves as pipeline-ready summary for this cross-specialty topic. Fukushima J Med Sci is a lower-impact journal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.